Considering the substantial therapeutic potential in targeting TDP‐43 and its pivotal role in the pathophysiology of numerous neurodegenerative diseases, it is crucial to understand how the apo structure of TDP‐43 diverges from the RNA‐bound structure and how the NTD domain can alter TDP‐43 function. The gene discussed is TARDBP; the disease is neurodegenerative disease.